Cancer Associated Thrombosis

This unique guide provides the core knowledge on epidemiology, prevention, diagnosis, therapy and overall management of patients with cancer-associated thrombosis, including case studies, and patient perspectives. The evidence base is highlighted throughout. This is a hugely valuable resource for the non-specialist on all aspects of thrombosis and malignancy and is ideal for general practitioners, junior doctors, specialist nurses and allied health professionals. Venous thromboembolism (VTE) is a common occurrence in patients with malignant disease. Prevention of VTE is the ultimate goal. Acute VTE is treated with anticoagulant therapy to prevent recurrent thrombosis, including potentially fatal pulmonary embolism (PE). The risk of recurrent thrombosis and the risk of anticoagulant-induced bleeding are increased in cancer patients compared to non-cancer patient. Every cancer patient should be individually assessed for the risk of VTE or the risk of recurrence of VTE and the balance between thrombosis and bleeding, weighed up, for each person. The book addresses all these key issues. The patient experience is a focus throughout the book. The table of contents maps the 'real life' cancer-associated thrombosis patient pathway for some patients.